Impairment of Host Liver Repopulation by Transplanted Hepatocytes in Aged Rats and the Release by Short-Term Growth Hormone Treatment.

Am J Pathol

Division of Applied Molecular Hepatology, Clinics and Policlinics of Visceral, Transplantation, Thoracic, and Vascular Surgery, University of Leipzig, Leipzig, Germany.

Published: March 2017

Hepatocyte transplantation is an alternative to whole liver transplantation. Yet, efficient liver repopulation by transplanted hepatocytes is low in livers of old animals. This restraint might be because of the poor proliferative capacity of aged donor hepatocytes or the regenerative impairment of the recipient livers. The age-dependent liver repopulation by transplanted wild-type hepatocytes was investigated in juvenile and senescent rats deficient in dipeptidyl-peptidase IV. Repopulation was quantified by flow cytometry and histochemical estimation of dipeptidyl-peptidase IV enzyme activity of donor cells in the negative host liver. As a potential pathway involved, expression of cell cycle proteins was assessed. Irrespective of the age of the donor hepatocytes, large cell clusters appeared in juvenile, but only small clusters in senescent host livers. Because juvenile and senescent donor hepatocytes were likewise functional, host-derived factor(s) impaired senescent host liver repopulation. Growth hormone levels were significantly higher in juvenile than in senescent rats, suggesting that growth hormone might promote host liver repopulation. Indeed, short-term treatment with growth hormone augmented senescent host liver repopulation involving the growth hormone-mediated release of the transcriptional blockade of genes associated with cell cycle progression. Short-term growth hormone substitution might improve liver repopulation by transplanted hepatocytes, thus augmenting the therapeutic benefit of clinical hepatocyte transplantation in older patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2016.11.016DOI Listing

Publication Analysis

Top Keywords

liver repopulation
28
host liver
20
growth hormone
20
repopulation transplanted
16
transplanted hepatocytes
12
donor hepatocytes
12
juvenile senescent
12
senescent host
12
liver
9
repopulation
8

Similar Publications

Host hepatocyte senescence determines the success of hepatocyte transplantation in a mouse model of liver injury.

J Hepatol

January 2025

Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, EH16 4UU, United Kingdom. Electronic address:

Background & Aims: Hepatocyte transplantation has shown promise for genetic diseases of the hepatocytes but to date has shown limited efficacy for non-genetic forms of severe liver injury. Limited cell engraftment and poor function of donor hepatocytes in recipient livers impacts the clinical utility of hepatocyte cell therapy. The mechanisms underpinning this are poorly understood.

View Article and Find Full Text PDF

Intrahepatic cholangiocarcinoma (ICC) is a highly lethal malignancy that currently lacks effective clinical treatments. Eliminating stem cell-like cancer cells is an extremely promising but challenging strategy for treating ICC. A recently developed synthetic retinoid, sulfarotene, abrogates proliferation, and induces apoptosis of tumor-repopulating cells (TRCs) that exhibit stem cell-like properties, yet its effect and underlying mechanisms remain elusive in ICC.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocyte transplantation (HTx) offers a new cell-based therapy for severe liver diseases but faces challenges like a lack of quality hepatocyte sources and low engraftment rates.
  • Researchers are exploring the use of small molecule drugs to enhance the quality of hepatocyte sources and support their functions.
  • The review will cover how small molecules can improve hepatocyte differentiation, reprogramming, and ultimately boost their engraftment and repopulation in liver therapies.
View Article and Find Full Text PDF
Article Synopsis
  • Somatic mutations in hematopoietic stem cells (HSCs) can give these cells a survival advantage, particularly affecting a crucial chromatin modifier gene involved in blood cell formation.* -
  • A study using a conditional loss of function model showed that this gene is vital for normal development of red and monocytic blood cells, revealing that HSCs lacking this gene fail to function properly despite having a normal number.* -
  • The absence of this gene leads to increased DNA damage and stress in HSCs, activating the p53 pathway, which emphasizes its critical role in preserving HSC function and genomic stability during blood cell development.*
View Article and Find Full Text PDF

Background And Aim: Bone marrow stem cells (BM-SCs) and their progeny play a central role in tissue repair and regeneration. In patients with chronic liver failure, bone marrow (BM) reserve is severally compromised and they showed marked defects in the resolution of injury and infection, leading to liver failure and the onset of decompensation. Whether BM failure is the cause or consequence of liver failure during cirrhosis is not known.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!